Abstract
dc:description.abstractDetachment of epithelial cells from matrix or attachment to an inappropriate matrix engages an apoptotic response known as anoikis, which prevents metastasis. Anoikis-resistance of tumor cells is critical for anchorage-independent growth and metastasis. Here we show two novel oncogenic pathways that confer resistance to anoikis in tumor cells. One pathway (chapter 2) signifies a new link between EMT and anoikis-resistance. In chapter 3, we present a new connection between inflammatory signaling pathways and anoikis-resistance. Cellular sensitivity to anoikis is compromised during the oncogenic epithelial-to-mesenchymal transition (EMT), through various mechanisms. Chapter 2 introduces a novel mechanism (NRAGE/TBX2/p14ARF) that is induced upon loss of E-cadherin and EMT, mediating anoikis resistance. The inflammatory-response transcription factor, NF-kB, contributes to anoikis-resistance and metastatic progression, through mechanisms that are understood incompletely. Deleted in Breast Cancer (DBC1) is over-expressed in several tumor types and correlates with a poorer prognosis in some cases. DBC1 suppressed anoikis in normal epithelial and breast cancer cell lines. Chapter 3 introduces a novel mechanism: DBC1 suppresses anoikis through enhancing canonical NF-kB signaling. This study will provide mechanisms for DBC1 to act as a tumor promoter, by providing a link between inflammation and anoikis-resistance and providing a potential target for anti-NF-eB/anti-cancer drugs.
Degree
thesis:*- Name thesis:degree_name
- PhD
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Microbiology, Immunology, and Cell Biology
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Park, Sun Hee
Subjects
dc:subject × 1Identifiers
dc:identifier.*- Identifier
- https://researchrepository.wvu.edu/etd/3658